-
Hims CEO Slams Novo Nordisk For 'Anticompetitive Demands' After Ozempic Maker Abruptly Ends Partnership: 'We Refuse To Be Strong-Armed'
Tuesday, June 24, 2025 - 3:06am | 899Read More...Hims & Hers Health Inc. (NYSE:HIMS), CEO Andrew Dudum, has accused Novo Nordisk of exerting anticompetitive pressure to prioritize its weight-loss drug Wegovy over patient needs after the abrupt termination of its partnership with a pharmaceutical giant. Check out the current price of HIMS...
-
'Shark Tank' Host Kevin O'Leary Says Hims & Hers CEO Should Have Been Fired For Backing Pro-Palestinian Protests
Tuesday, May 7, 2024 - 6:30am | 630Read More...In a recent interview, Kevin O’Leary, the host of “Shark Tank,” criticized Andrew Dudum, the CEO of Hims & Hers, for his support of pro-Palestinian student protests. O’Leary suggested that Dudum should have been fired immediately for his stance. What Happened: O’...
-
Hims & Hers Health CEO Under Fire After Expressing Support For Pro-Palestinian Student Protesters, Company Stock Plummets
Sunday, May 5, 2024 - 11:01am | 539Read More...Hims & Hers Health Inc. (NYSE: HIMS) stock was hit significantly on Friday following its CEO's public support for pro-Palestinian protesters. What Happened: The company's stock plummeted by 8% during Friday's trading session due to CEO Andrew Dudum's public endorsement...
-
Why Hims & Hers Health Shares Are Rising After Hours
Monday, February 27, 2023 - 6:04pm | 430Read More...Hims & Hers Health Inc (NYSE: HIMS) shares are trading higher after hours Monday after the company turned in a strong fourth-quarter report and issued guidance above analyst estimates. What Happened: Hims & Hers said fourth-quarter revenue nearly doubled on a year-over-year...
-
Why Hims & Hers Health Shares Are Trading Higher Today
Thursday, August 12, 2021 - 3:07pm | 228Read More...Hims & Hers Health Inc (NYSE: HIMS) is trading higher Thursday after the company announced better-than-expected second-quarter financial results and issued guidance above estimates. Hims & Hers Health reported a quarterly earnings loss of 5 cents per share, which beat the estimate for a...
